Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Cell Signaling Technologies" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Cell Signaling Technologies for you to read. Along with our medical data and news we also list Cell Signaling Technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cell Signaling Technologies Companies for you to search.
Cells need for reactions on environmental changes and a balanced system of signaling cascades within the cell. Proteins outside of the cell, on the cellular surface, inside the cellular membrane, and within the cell orchestrate many fine-tuned signaling pathways, which result in adequate reactions on the environmental conditions or changes in the organism itself.
The first known immortalized cell line with a naturally-occurring inactivating mutation in PRKAR1A, the regulatory subunit type 1A (R1alpha) of protein kinase A (PKA), which is associated with tumor formation.Read more about Human Cell Line for Studies on Signaling and Endocrine Cancer
The mammalian Hippo signaling pathway, through its effectors YAP and TAZ, coerces epithelial progenitor cell expansion for appropriate tissue development or regeneration upon damage. Its ability to drive rapid tissue growth explains why many oncogenic events frequently exploit this pathway to promote cancer phenotypes. Indeed, several tumor types including basal cell carcinoma (BCC) show genetic a...
The quality of a cell signal, not just its strength, can determine whether a cell will follow a path toward cancer. This finding, which emerged from optogenetic interrogations of both healthy cells and cancer cells, stresses the importance of signal timing, or rather, the ability of cells to “hear” signals distinctly enough to respond appropriately. Unfortunately, mutations that affect signali...
NewsResearch into cell-to-cell signaling mechanism may lead to new cancer treatments.
In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research applications. The company is now at the ‘end of the beginning stage’, and has the capability to mass produce stem cells, with which it hopes to provide a range of products and services. The impact ...
In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies. Filmed at AusBiotech 2009, they discuss: • The company’s origins and aims • Pig islet transplantation to combat diabetes • Results of Russian and New Zealand clinical trials • Living Cell Technologies’ issues with clinical trials in Australia • The company’s searc...
(Vanderbilt University Medical Center) The cellular nutrient glutamine launches a metabolic signaling pathway that promotes the function of some immune system T cells and suppresses others, Vanderbilt researchers have discovered.They show that a drug that inhibits glutamine metabolism -- currently in clinical trials as an anticancer agent -- might be useful as a treatment for inflammatory and auto...
Cell–cell and cell–matrix interactions guide organ development and homeostasis by controlling lineage specification and maintenance, but the underlying molecular principles are largely unknown. Here, we show that in human developing cardiomyocytes cell–cell contacts at the intercalated disk connect to remodeling of the actin cytoskeleton by regulating the RhoA-ROCK signaling to m...
A study conducted by researchers from The Sainsbury Laboratory, the University of Zurich, and the University of Washington has identified the mechanisms by which a common plant co-receptor can regulate many different signaling pathways through protein phosphorylation that the researchers call a ‘phosphocode'. Cell-surface receptors are important to...
The first known immortalized cell line with a naturally-occurring inactivating mutation in PRKAR1A, the regulatory subunit type 1A (R1alpha) of protein kinase A (PKA), which is associated with tumor formation.Read more about A Novel Immortalized Human Adrenal Cell Line with Inactive Protein Kinase A for Studies on cAMP Signaling and Endocrine Tumorigenesis
DUBLIN, Nov. 2, 2018 /PRNewswire/ -- The "High Content Screening/Imaging: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The HCS/I market has Read more...
Shanghai Cell Therapy completed a $40 million Series C1 financing, led by China Industrial Asset Management, which contributed $26 million of the total. Shanghai Cell Therapy is developing oncology drugs based on precision medicine and cell therapy technologies. The company has established the Shanghai Wu Mengchao-Nobel Laureate Joint Medical Technology and Innovation Center. It claims the center ...
This 500-page catalog features listings and descriptions on over 1000 bioreagents and research kits, used for research in cell biology and
CAR T-cell therapy, which reprograms immune cells to fight cancer, has shown great promise in people with some blood cancers who have not responded to other treatments. But until now, the underlying biological pathways enabling anti-cancer responses have not been thoroughly examined.